Advertisement

Infection

, Volume 24, Issue 2, pp 182–186 | Cite as

Physician preferences in the diagnosis and treatment of Lyme disease in the United States

  • Martina H. Ziska
  • S. T. Donta
  • F. C. Demarest
Special Addendum — Part II Therapy And Prophylaxis In Lyme Borreliosis

Summary

To assess physician preferences in the diagnosis and treatment of Lyme disease, questionnaires were sent to physicians in various Lyme disease endemic areas in the U. S. Seventy-eight responses were analyzed. Both ELISA and Western blot were ordered by 86% of responders. Fifty percent of responders believed that 25% or more of patients who have Lyme disease were seronegative. The treatment was influenced by physician specialty. Antibiotic treatment for tick bite was prescribed by 20% of responders. Erythema migrans rash was treated by all responders without serologic confirmation. The median treatment duration of erythema migrans was 4 weeks. For post-erythema migrans Lyme disease, 43% of responders treat 3 months or more; for chronic Lyme disease, 57% of responders treat 3 months or more. Our survey documents significant differences between published recommendations and actual practices. Physician education and clinical trials are needed to clarify the reasons for these differences.

Keywords

Western Blot United States Antibiotic Treatment Treatment Duration Endemic Area 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Bevorzugte Methoden in der Diagnostik und Therapie der Lyme-Borreliose bei amerikanischen Ärzten

Zusammenfassung

Zur Erhebung von Daten zur Präferenz amerikanischer Ärzte in der Diagnostik und Therapie der Lyme-Borreliose wurden in verschiedenen endemischen Gebieten der USA Fragebogen an Ärzte verschickt. 78 Antworten wurden ausgewertet. 86% der Befragten forderten eine Untersuchung mittels ELISA und Western Blot. 50% der Befragten gaben an, daß ihrer Ansicht nach 25% der Patienten mit Lyme-Borreliose seronegativ sind. In der Therapiewahl ist ein Einfluß der Spezialisierung der Ärzte zu erkennen. 20% der Befragten verordnen nach Zeckenstich ein Antibiotikum. Alle Ärzte gaben an, das Erythema migrans auch ohne serologische Bestätigung mit Antibiotika zu behandeln. Die mediane Behandlungsdauer bei Erythema migrans betrug 4 Wochen. Eine nach Erythema migrans auftretende Lyme Borreliose wurde von 43% der Befragten 3 Monate oder länger behandelt. Die von uns durchgeführte Umfrage deckte erhebliche Unterschiede zwischen publizierten Empfehlungen und der Praxis auf. Es ist erforderlich, die Gründe für diese Unterschiede aufzuklären und den Ärzten Fortbildung anzubieten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burgdorfer, W., Barbour, A. G., Hayes, S. F., Benach, J. L., Grunwaldt, E., Davis, J. P. Lyme disease — a tick-borne spirochetosis? Science 216 (1982) 1317–1319.Google Scholar
  2. 2.
    MMWR 43 (1995) 963.Google Scholar
  3. 3.
    Bakken, L. L., Case, K. L., Callister, S. M., Bourdeau, M. J., Schell, R. F. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 268 (1992) 891–895.Google Scholar
  4. 4.
    Dattwyler, R. J., Volkman, D. J., Luft, B. J., Halperin, J. J., Thomas, J., Golightly, M. G. Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses toBorrelia burgdorferi. N. Engl. J. Med. 319 (1988) 1441–1446.Google Scholar
  5. 5.
    Schutzer, S. E., Coyle, P. K., Belman, A. L., Golightly, M. G., Drulle, J. Sequestration of antibody toBorrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 335 (1990) 312–315.Google Scholar
  6. 6.
    Steere, A. C., Taylor, E., McHugh, G. L., Logigian, E. L. The over-diagnosis of Lyme disease. JAMA 269 (1993) 1812–1816.Google Scholar
  7. 7.
    Sigal, L. H. Summary of the first 100 patients seen at a Lyme disease referral center. Am. J. Med. 88 (1990) 577–581.Google Scholar
  8. 8.
    Eppes, S. C., Klein, J. D., Caputo, G. M., Rose, C. D. Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area. Clin. Pediatr. (Phila.) 33 (1994) 130–134.Google Scholar
  9. 9.
    Jung, P. I., Nahas, J. N., Strickland, G. T., McCarter, R., Israel, E. Maryland physicians' survey on Lyme disease. Md. Med. J. 43 (1994) 447–450.Google Scholar
  10. 10.
    Strickland, G. T., Caisley, I., Woubeshet, M., Israel, E. Antibiotic therapy for Lyme disease in Maryland. Public Health Rep. 109 (1994) 745–749.Google Scholar
  11. 11.
    Steere, A. C., Malawista, S. E., Snydman, D. R., Shope, R. E., Andiman, W. A., Ross, M. R., Steele, F. M. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20 (1977) 7–17.Google Scholar
  12. 12.
    Duray, P. H. Clinical pathologic correlations of Lyme disease. Rev. Infect. Dis. 11 (Suppl. 6) (1989) S 1487–1493.Google Scholar
  13. 13.
    Kantor, F. S. Disarming Lyme disease. Sci. Am. 271 (1994) 34–39.Google Scholar
  14. 14.
    National Institutes of Health Diagnosis and treatment of Lyme disease. Clinical Courier 9 (1991) 1–8.Google Scholar
  15. 15.
    Corpuz, M., Hilton, E., Lardis, M. P., Singer, C., Zolan, J. Problems in the use of serologic tests for the diagnosis of Lyme disease. Arch. Intern. Med. 151 (1991) 1837–1840.Google Scholar
  16. 16.
    Tilton, R. C. Laboratory aids for the diagnosis ofBorrelia burgdorferi infection. J. Spirochetal Tick-Borne Dis. 1 (1994) 18–23.Google Scholar
  17. 17.
    Luger, S. W., Kraus, E. Serologic tests of Lyme disease: interlaboratory variability. Arch. Intern. Med. 150 (1990) 761–763.Google Scholar
  18. 18.
    Schwartz, B. S., Goldstein, M. D., Ribeiro, J. M., Schulze, T. L., Shahield, S. I. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA 262 (1992) 3431–3434.Google Scholar
  19. 19.
    Berger, B. W. Cutaneous manifestations of Lyme borreliosis. Rheum. Dis. Clin. North Am. 15 (1989) 627–634.Google Scholar
  20. 20.
    Shadick, N. A., Phillips, C. B., Logigian, E. L., Steere, A. C., Kaplan, R. F., Berardi, V. P., Duray, P. H., Larson, M. G., Wright, E. A., Ginsburg, K. S., Katz, J. N., Liang, M. H. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann. Intern. Med. 121 (1994) 560–567.Google Scholar
  21. 21.
    Asch, E. S., Bujak, D. I., Weiss, M., Peterson, M. G., Weinstein, A. Lyme disease: an infectious and postinfectious syndrome. J. Rheumatol. 21 (1994) 454–461.Google Scholar
  22. 22.
    Liegner, K. B. Lyme disease: the sensible pursuit of answers. J. Clin. Microbiol. 31 (1993) 1961–1963.Google Scholar
  23. 23.
    Shapiro, E. D., Gerber, M. A., Holabird, N. B., Berg, A. T., Feder, H. M. Jr., Bell, G. L., Rys, P. N., Persing, D. H. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N. Engl. J. Med. 327 (1992) 1769–1773.Google Scholar
  24. 24.
    Magid, D., Schwartz, B., Craft, J., Schwartz, J. S. Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N. Engl. J. Med. 327 (1992) 534–541.Google Scholar
  25. 25.
    Luft, B. J., Dattwyler, R. J. Treatment of Lyme borreliosis. Rheum. Dis. Clin. North Am. 15 (1989) 747–755.Google Scholar
  26. 26.
    Haupl, T., Hahn, G., Rittig, M., Krause, A., Schoerner, C., Schonherr, U., Kalden, J. R., Burmester, G. R. Persistence ofBorrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 36 (1993) 1621–1626.Google Scholar
  27. 27.
    Klempner, M. S., Noring, R., Rogers, R. A. Invasion of human skin fibroblasts by the Lyme disease spirochete,Borrelia burgdorferi. J. Infect. Dis. 167 (1993) 1074–1081.Google Scholar
  28. 28.
    Wahlberg, P., Granlund, H., Nyman, D., Panelius, J., Seppala, I. Treatment of late Lyme borreliosis. J. Infect. 29 (1994) 255–261.Google Scholar
  29. 29.
    Lawrence, C., Lipton, R. B., Lowy, F. D., Coyle, P. K. Seronegative chronic relapsing neuroborreliosis. European Neurology 35 (1995) 113–117.Google Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1996

Authors and Affiliations

  • Martina H. Ziska
    • 1
  • S. T. Donta
    • 2
  • F. C. Demarest
    • 3
  1. 1.Lyme Disease FoundationHartford
  2. 2.Boston University and Boston VA Medical CentersBoston
  3. 3.Zygo CorporationMiddlefieldUSA

Personalised recommendations